688197 首藥控股
按盤價 
38.410 -0.100 (-0.260%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -6.476 | -23.163 | -16.662 | -28.777 | -195.939 |
| 總資產報酬率 ROA (%) | -5.679 | -20.836 | -15.391 | -25.610 | -123.473 |
| 投入資產回報率 ROIC (%) | -6.417 | -23.029 | -16.570 | -28.483 | -191.191 | 邊際利潤分析 |
| 銷售毛利率 (%) | 100.000 | 98.956 | 97.871 | 99.371 | 99.932 |
| 營業利潤率 (%) | -2,552.387 | -5,376.314 | -3,548.333 | -9,518.597 | -1,116.806 |
| 息稅前利潤/營業總收入 (%) | -2,546.317 | -5,511.391 | -3,911.122 | -10,613.206 | -1,122.645 |
| 淨利潤/營業總收入 (%) | -2,537.551 | -5,376.400 | -3,548.792 | -9,512.739 | -1,111.996 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 110.343 | 106.795 | 107.506 | 114.578 | 112.123 |
| 價值變動淨收益/利潤總額(%) | -9.621 | -8.186 | -3.827 | -0.655 | 0.000 |
| 營業外收支淨額/利潤總額(%) | -0.585 | 0.002 | 0.013 | -0.062 | -0.433 | 償債能力分析 |
| 流動比率 (X) | 6.946 | 7.054 | 10.898 | 13.495 | 0.687 |
| 速動比率 (X) | 6.931 | 7.024 | 10.895 | 13.469 | 0.659 |
| 資產負債率 (%) | 12.362 | 12.276 | 8.197 | 7.137 | 97.419 |
| 帶息債務/全部投入資本 (%) | 0.763 | 0.573 | 0.221 | 0.485 | -3.823 |
| 股東權益/帶息債務 (%) | 12,987.999 | 17,304.741 | 45,149.973 | 20,485.261 | -803.100 |
| 股東權益/負債合計 (%) | 708.922 | 714.581 | 1,119.970 | 1,301.084 | 2.650 |
| 利息保障倍數 (X) | 290.467 | 40.828 | 10.794 | 9.644 | 105.421 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 44.800 | 8.321 | 0.000 | 374.343 | 52.484 |
| 存貨周轉天數 (天) | -- | 16,031.738 | 4,113.774 | 58,806.566 | 85,920.599 |
| 備註： | 即時報價更新時間為 03/06/2025 16:21 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
